The Deerfield-based medical device and pharmaceutical company is facing down a balance sheet loaded with debt and business ...
2d
Assessing Baxter International (BAX) Valuation After Mixed Short And Long Term Shareholder Returns
Is On Investors’ Radar Today Baxter International (BAX) has drawn interest after a recent stretch where its shares show mixed performance across different timeframes. This has prompted investors to ...
Baxter (BAX) stock: deep 30–50% valuation discount but limited catalysts as CEO focuses on cuts and deleveraging; learn key ...
At the 2026 J.P. Morgan Healthcare Conference, Baxter International announced the upcoming U.S. launch of its Dynamo Series stretcher, now available for order and expected to enter hospitals in the ...
StockStory.org on MSN
Why Baxter (BAX) stock is trading lower today
What Happened? Shares of healthcare company Baxter International (NYSE:BAX) fell 4.5% in the afternoon session after Barclays ...
With a market cap of $10.3 billion, Baxter International Inc. (BAX) provides a broad portfolio of medical products, ...
Versatile, scalable design allows a range of procedures to be performed in-stretcher, reducing the need for unnecessary ...
On a revised dealmaking spree this year, Korea’s Samsung Biologics is re-tooling its long-running drug manufacturing pact with Baxter Healthcare. The retooled deal, first established back in July of ...
NEW YORK, May 17 (Reuters) - Baxter International Inc shares fell 3 percent on Monday after its partner Halozyme Therapeutics Inc voluntarily recalled certain lots of their fluid-absorption drug due ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback